Fingerprint
Dive into the research topics of 'Trastuzumab tolerability in the treatment of advanced (stage III-IV) or recurrent uterine serous carcinomas that overexpress HER2/neu'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically